Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02460289 · ClinicalTrials.gov registry record · NA
Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia
A NA study of Male Pattern of Hair Loss, Androgenic Alopecia, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT02460289 is a NA study of Male Pattern of Hair Loss, Androgenic Alopecia that has completed, run by Galderma R&D. The registered enrollment target is 63 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02460289, a NA study of Male Pattern of Hair Loss, Androgenic Alopecia, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize the effect of Minoxidil 5% Foam and Botanical Hair Solution Regimen in men with thinning hair and male pattern hair loss/androgenic alopecia (Norwood III \& IV).
Conditions Studied
Interventions
- DRUG Treatment: Minoxidil 5% / Botanical Hair Solution for Men
Study Locations (1)
Texas
- Stephens & Associates - Richardson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2015-05-19 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02460289
The ClinicalTrials.gov registry entry for NCT02460289 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Male Pattern of Hair Loss, Androgenic Alopecia appearing as the primary indexed condition, and to 1 intervention - of which Treatment: Minoxidil 5% / Botanical Hair Solution for Men is the first listed.
NCT02460289 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02460289 about?
NCT02460289 is a clinical study titled "Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia". The purpose of this study is to characterize the effect of Minoxidil 5% Foam and Botanical Hair Solution Regimen in men with thinning hair and male pattern hair loss/androgenic alopecia (Norwood III \& IV).
What is the current status of trial NCT02460289?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2015-05-19. Estimated completion is 2015-11.
What conditions does trial NCT02460289 study?
This clinical trial studies the following conditions: Male Pattern of Hair Loss, Androgenic Alopecia.
What interventions are being tested in trial NCT02460289?
The interventions under investigation include: Treatment: Minoxidil 5% / Botanical Hair Solution for Men (DRUG).
Who is sponsoring clinical trial NCT02460289?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02460289 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.